Clinical Trial Update: Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy, safety, and tolerability of rivastigmine patch in mild-to-moderate Alzheimer's disease patients who previously use…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Rivastigmine Patch (Rivastigmine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED